GUAIFENESIN tablet

Ország: Egyesült Államok

Nyelv: angol

Forrás: NLM (National Library of Medicine)

Aktív összetevők:

GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ)

Beszerezhető a:

AvPAK

INN (nemzetközi neve):

GUAIFENESIN

Összetétel:

GUAIFENESIN 200 mg

Recept típusa:

OTC DRUG

Engedélyezési státusz:

OTC monograph final

Termékjellemzők

GUAIFENESIN - GUAIFENESIN TABLET
AVPAK
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
GUAIFENESIN TABLETS USP, 200 MG
DRUG FACTS
ACTIVE INGREDIENT
(IN EACH IMMEDIATE-RELEASE TABLET)
Guaifenesin USP, 200 mg
PURPOS E
Expectorant
US ES
Helps loosen phlegm(mucus) and thin bronchial secretions to rid the
bronchial passageways of
bothersome mucus and make coughs more productive
WARNINGS
ASK A DOCTOR BEFORE USE IF YOU HAVE
persistent or chronic cough such as occurs with smoking, asthma,
chronic bronchitis, or emphysema
cough accompanied by too much phlegm(mucus)
STOP USE AND ASK A DOCTOR IF cough lasts more than 7 days, comes back,
or is accompanied by fever,
rash or persistent headache. This could be signs of a serious illness.
IF PREGNANT OR BREAST-FEEDING, ask a health professional before use.
KEEP OUT OF REACH OF CHILDREN.
In case of overdose, get medical help or contact a Poison Control
Center right away.
DIRECTIONS
do not take more than 6 doses in any 24-hour period
this product is not intended for use in children under 12 years of age
adults and children 12 years and over
1 to 2 tablets every 4 hours
Children under 12 years
Do not use
OTHER INFORMATION
store at 15-30 °C (59-86 °F)
you may report serious side effects to: AvKARE, Inc. at 1 (855)
361-3993
INACTIVE INGREDIENTS
Colloidal silicon dioxide, FD&C red #40(Al-lake), magnesium stearate,
maltodextrin, microcrystalline
cellulose, povidone, stearic acid
MANUFACTURED FOR: AVKARE, INC., PULASKI, TN 38478
MFG. REV. 04/15 AV 09/16 (P)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 50268-382-15
GUAIFENESIN TABLETS USP
200mg
EXPECTORANT
For Ages 12 and Over
50 Tablets (5 x 10) Unit Dose
5026838215
NDC 50268-382-15
GUAIFENESIN TABLETS USP
200mg
EXPECTORANT
For Ages 12 and Over
50 Tablets (5 x 10) Unit Dose
5026838215
DRUG FACTS
ACTIVE INGREDIENT PURPOSE
(IN EACH IMMEDIATE-RELEASE TABLET)
Guaifenesin US